CIK 0000728387
- Non-accelerated filer
- Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411458152
- Phone
- +1 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy CEO bought 10,000 shares at an average $0.52 ($5,155)
- 4/A Open-market buy CEO bought 10,500 shares at an average $0.54 ($5,655)
- 4/A Open-market buy CEO bought 20,000 shares at $0.68 ($13,600)
- 4/A Open-market buy CEO bought 4,500 shares at an average $0.80 ($3,611)
- 4 Open-market buy CEO bought 10,000 shares at an average $0.52 ($5,155)
- 4 Open-market buy CEO bought 10,500 shares at an average $0.54 ($5,655)
- 4 Open-market buy CEO bought 20,000 shares at $0.68 ($13,600)
- 4 Open-market buy CEO bought 4,600 shares at an average $0.80 ($3,696)
- 4 Open-market buy CEO bought 10,000 shares at an average $0.52 ($5,155)
- 4 Open-market buy CEO bought 10,500 shares at an average $0.54 ($5,655)
- 4 Open-market buy CEO bought 20,000 shares at $0.68 ($13,600)
- 4 Open-market buy CEO bought 4,600 shares at an average $0.80 ($3,696)
- 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Controller sold 11,333 shares at $1.00 ($11,333)
Page 13 of 18 · 341 filings